Showing results (131-140 of 150) with videos related to
Sort By:
Pageof 15
ACS Chemical Neuroscience|June 20, 2018
Modulating Protein Phosphatase 2A Rescues Disease Phenotype in Neurodegenerative TauopathiesSimon McKenzie-Nickson, Jacky Chan, Keyla Perez, et al.Dalton Transactions (Cambridge, England : 2003)|December 18, 2014
Rhenium and technetium complexes that bind to amyloid-β plaquesDavid J Hayne, Andrea J North, Michelle Fodero-Tavoletti, et al.Metallomics : Integrated Biometal Science|September 1, 2018
Targeting metals rescues the phenotype in an animal model of tauopathyAmelia Sedjahtera, Lydia Gunawan, Lisa Bray, et al.Plos One|June 21, 2007
Mitochondrial oxidative stress causes hyperphosphorylation of tauSimon Melov, Paul A Adlard, Karl Morten, et al.Journal of Parkinson'S Disease|August 9, 2021
ATH434 Reverses Colorectal Dysfunction in the A53T Mouse Model of Parkinson's DiseaseShanti Diwakarla, Rachel M McQuade, Remy Constable, et al.Journal of Neurochemistry|July 30, 2011
The Alzheimer's therapeutic PBT2 promotes amyloid-β degradation and GSK3 phosphorylation via a metal chaperone activityPeter J Crouch, Maria S Savva, Lin W Hung, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 28, 2007
In vitro characterization of Pittsburgh compound-B binding to Lewy bodiesMichelle T Fodero-Tavoletti, David P Smith, Catriona A McLean, et al.Iscience|January 31, 2024
Behavioral, metabolic, and lipidomic characterization of the 5xFADxTg30 mouse model of Alzheimer's diseaseJ P S Marshall, K Huynh, G I Lancaster, et al.Nature Medicine|January 31, 2012
Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron exportPeng Lei, Scott Ayton, David I Finkelstein, et al.Scientific Reports|December 10, 2015
Loss of synaptic Zn2+ transporter function increases risk of febrile seizuresMichael S Hildebrand, A Marie Phillips, Saul A Mullen, et al.Pageof 15